The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

About

Our approach is translational - It starts from a specific need, identified by our clinical partners. We use novel technological approaches to find the relevant solutions, which can be implemented into the clinic with much shorter lead times.

CREATE Health, inaugurated in 2006 with a focus on precision medicine, is a strategic centre for translational research focusing on the early diagnosis and prognosis of cancer, as well as the development of novel treatment strategies.

CREATE Health, inaugurated in 2006 with a focus on precision medicine, is a strategic centre for translational research focusing on the early diagnosis and prognosis of cancer, as well as the development of novel treatment strategies.

Today CREATE consists of scientists from four different faculties: medicine, engineering, natural sciences and social sciences, hosted by LTH and is located at Medicon Village in Lund. CREATE Health brings together, both physically and logistically, researchers from such diverse fields as bioinformatics, nanotechnology, proteomics, transcriptomics, cancer genetics and tumor cell biology with clinical oncologists from Lund University Hospital, thereby creating a unique integrative environment highly qualified for solving complex clinical problems.

Antibody engineering. Illustration.